MyFinsight
Home
Blog
About
Contact
pvct: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$205,509
Cash
$72,479
Operating lease
right-of-use asset
$138,451
Equipment and
furnishings, less...
$3,465
Total current assets
$277,988
Accumulated deficit
-$261,688,770
Accumulated other
comprehensive loss
-$60,327
Total assets
$419,904
Non-controlling interest in
subsidiary
-$16,178
Total provectus
biopharmaceuticals, inc.,...
-$6,150,832
Additional paid-in capital
$255,163,053
Common stock par value
0.001 per share...
$420,280
Preferred stock,
value-Series DOne...
$13,975
Preferred stock,
value-Series DConvertible...
$957
Total liabilities and
stockholders deficit
$419,904
Total stockholders
deficit
-$6,167,010
Total liabilities
$6,586,914
Operating lease
liability, non-current...
$91,637
Notes payable,
non-current portion
$23,621
Total current
liabilities
$6,471,656
Operating lease
liability, current portion
$47,152
Convertible notes
payable-Related Party
$1,125,000
Convertible notes
payable-Nonrelated Party
$1,050,000
Notes payable
$105,860
Other accrued
expenses
$2,824,285
Accrued
interest-Related Party
$97,450
Accrued
interest-Nonrelated Party
$44,133
Accounts payable
$1,177,776
Back
Back
Balance Sheet
source: myfinsight.com
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)